MedTrace Logo

Post-Approval Study for the MOSAIC® Bioprostheses

NCT01574625 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 177

Last updated 2019-05-01

No results posted yet for this study

Summary

A Single Center Non-Interventional Post-Market Release, Long Term Follow Up study of patients who underwent Isolated Aortic Valve Replacement or Isolated Mitral Valve Replacement with a Medtronic Mosaic Bioprosthesis. The purpose of this study is to evaluate the long term safety, efficacy and clinical performance of the Mosaic Bioprostheses.

Conditions

  • Aortic Valve Stenosis and/or Insufficiency
  • Mitral Valve Stenosis and/or Insufficiency

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Friedrich Christian Rieß, Prof. Dr. · Albertinen Krankenhaus

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-04-30
Primary Completion
2018-02-28
Completion
2018-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01574625 on ClinicalTrials.gov